Loading...
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial vulnerability assessment tool by 360 Security Group (Qihoo 360). VulnCheck is a commercial vulnerability assessment tool by VulnCheck. Compare features, ratings, integrations, and community reviews side by side to find the best vulnerability assessment fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Security teams tired of patching vulnerabilities that aren't actually exploited in the wild should use VulnCheck for its early access to exploit proof-of-concepts and real-time threat landscape scoring that actually prioritizes what matters. The platform covers ID.RA and DE.CM functions through in-house PoCs and internet sensor data that surface exploitation signals weeks before public disclosure, giving you decision velocity NVD feeds simply cannot match. Skip this if your organization lacks the analyst bandwidth to act on daily vulnerability intelligence or needs vulnerability management bundled with patch orchestration; VulnCheck is intelligence-first, not ticketing-first.
Tool that immunizes Windows systems against critical vulnerabilities
Vuln & exploit intelligence platform for prioritizing vulnerability response
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs VulnCheck for your vulnerability assessment needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). headquartered in China. Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
VulnCheck: Vuln & exploit intelligence platform for prioritizing vulnerability response. built by VulnCheck. headquartered in United States. Core capabilities include Early access to vulnerability information not in NVD, In-house developed exploit proof-of-concepts, Packet captures for initial access vulnerabilities..
Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.
Get strategic cybersecurity insights in your inbox